Center for Clinical Research

Clinical research studies aim to answer specific questions about
how medicines work in the volunteers who take them. You should
feel fully informed about what to expect from participation in a
clinical research study.

Clinical research study for people with type 2 diabetes being treated with insulin glargine therapy.

ACHIEVE-5 is a new clinical research study from Eli Lilly and Company. It is testing if an investigational medicine (a medicine being studied) may help treat people with type 2 diabetes.

Learn About the AVANTI Study – Step Up and Be Part of Primary Hypothyroidism Research.

If you’re being treated for primary hypothyroidism but are still experiencing symptoms, you might consider enrolling in the AVANTI Study of an investigational medication.

TRIUMPH-OUTCOMES is a clinical research study for people with excess weight who also have heart disease or kidney disease, or both.

The study will test if the investigational medicine (a medicine being studied) may help reduce the risk for heart disease and kidney disease in people with excess weight.

REDEFINE 3 is looking at the combination of cagrilinitideand semaglutide (CagriSema), which has the potential to impact cardiovascular risk factors.

Participating in this clinical study has the potential to improve future treatment options for people living with cardiovascular disease.

In this study, the new investigational combination study medicine will be compared to a type 2 diabetes medicine called tirzepatide. The participants will either get the new investigational combination study medicine in one dose (2.4 mg/2.4 mg) or tirzepatide (15 mg). Which treatment the participants get is decided by chance. The treatment is given as an injection once a week throughout the treatment period.